Accelovance, Inc — Melbourne, Florida

Accelovance, Inc is a clinical research site located in Melbourne, Florida, United States 32935.

Crixeo Health Trust Score: 58/100 (POOR). This profile has not yet been claimed by the site owner.

Accelovance, Inc has participated in 2 clinical trials.

Therapeutic areas: Migraine Headache, Meningococcal Disease.

Sponsors: Eli Lilly and Company, Novartis Vaccines.

Sponsor Feasibility Report

Trust Score: 58/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Accelovance, Inc?

Accelovance, Inc has a Crixeo Trust Score of 58/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Accelovance, Inc conducted?

Accelovance, Inc has 2 clinical trials on record. Their work covers Migraine Headache, Meningococcal Disease.

Is Accelovance, Inc accredited by Crixeo Health?

Accelovance, Inc has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Accelovance, Inc?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.